http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9813779-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1394e66eb648f9bf0a1f5507fe25b67b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 1998-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791b8eb46540ec87ded81845658bd3b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4907ee2d1ad8c4e62562bf5c06805da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfe9115563f9a79bf0cabbfcc03beb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a196231f8b0671420822e6c972e1f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22fac4ca52bac08cfdc81638a568bb64
publicationDate 2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9813779-A
titleOfInvention New taxane derivatives
abstract Invention Patent "NEW DERIVATIVES FROM TAXAN". The present invention relates to the Taxane derivatives, represented by the formula (1): [where, A¹ represents a group (formula of line 5) (in which R¹ represents an H, or a (substituted alkyl group) or a group (Formula of line 7) (in which R² represents an amine group, a mono- or di-alkylamine group, a piperidine group, a pyrolidine group or a morpholino group), X represents an H, an alkoxycarbonyl group, or a benzoyl group, Y represents H or a trialkylsilyl group, A² represents a furyl group, an alkylfuryl group, an alkyl group or a fluorophenyl group, Ac represents an acetyl group, and Bz represents a benzoyl group] or salts thereof; and drugs containing the same as an active ingredient. These compounds have excellent water solubility and anti-tumor activity.
priorityDate 1997-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457472442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 35.